Treg Heterogeneity, Function, and Homeostasis

Daniil Shevyrev, Valeriy Tereshchenko, Daniil Shevyrev, Valeriy Tereshchenko

Abstract

T-regulatory cells (Tregs) represent a unique subpopulation of helper T-cells by maintaining immune equilibrium using various mechanisms. The role of T-cell receptors (TCR) in providing homeostasis and activation of conventional T-cells is well-known; however, for Tregs, this area is understudied. In the last two decades, evidence has accumulated to confirm the importance of the TCR in Treg homeostasis and antigen-specific immune response regulation. In this review, we describe the current view of Treg subset heterogeneity, homeostasis and function in the context of TCR involvement. Recent studies of the TCR repertoire of Tregs, combined with single-cell gene expression analysis, revealed the importance of TCR specificity in shaping Treg phenotype diversity, their functions and homeostatic maintenance in various tissues. We propose that Tregs, like conventional T-helper cells, act to a great extent in an antigen-specific manner, which is provided by a specific distribution of Tregs in niches.

Keywords: T-regulatory cell; TCR repertoire; TCR—T cell receptor; antigen-specific activation; immune equilibrium; single-cell analysis (SCA).

Copyright © 2020 Shevyrev and Tereshchenko.

Figures

Figure 1
Figure 1
Treg lymphocyte differentiation dynamics.
Figure 2
Figure 2
Transcription heterogeneity of the Treg population.
Figure 3
Figure 3
Mechanisms of Treg suppression.
Figure 4
Figure 4
Schematic presentation of a Treg niche.

References

    1. Redmond AK, Macqueen DJ, Dooley H. Phylotranscriptomics suggests the jawed vertebrate ancestor could generate diverse helper and regulatory T cell subsets. BMC Evol Biol. (2018) 18:169. 10.1186/s12862-018-1290-2
    1. Cao J, Chen Q, Lu M, Hu X, Wang M. Histology and ultrastructure of the thymus during development in tilapia, Oreochromis niloticus. J Anat. (2017) 230:720–33. 10.1111/joa.12597
    1. Sugimoto K, Hui PS, Sheng DZ, Nakayama M, Kikuchi K. Zebrafish FOXP3 is required for the maintenance of immune tolerance. Dev. Comp. Immunol. (2017) 73:156–62. 10.1016/j.dci.2017.03.023
    1. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol. (1988) 140:4245–52.
    1. O'Connor WJ, Kamanaka M, Booth CJ, Terrence T, Susumu N, Iwakura Y, et al. . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. (2009) 10:603–9. 10.1038/ni.1736
    1. Wurster AL, Rodgers VL, Satoskar AR. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med. (2002) 196:969–77. 10.1084/jem.20020620
    1. Yssel H, Malefyt WR, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, et al. . IL-10 is produced by subsets of human CD4 + T cell clones and peripheral blood T cells. J Immunol. (1992) 149:2378–84.
    1. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. (2012) 150:29–38. 10.1016/j.cell.2012.05.031
    1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. (2008) 133:775–87. 10.1016/j.cell.2008.05.009
    1. Dembic Z. Beginning of the end of (understanding) the immune response. Scand J Immunol. (2008) 68:381–2. 10.1111/j.1365-3083.2008.02159.x
    1. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol. (2001) 167:4245–53. 10.4049/jimmunol.167.8.4245
    1. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. (2004) 5:266–71. 10.1038/ni1037
    1. Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. (2017) 356:1026–30. 10.1126/science.aam7928
    1. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. . FOXP3+ T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLoS ONE. (2015) 10:e0128094. 10.1371/journal.pone.0128094
    1. Ali N, Zirak B, Rodriguez RS, Pauli ML, Truong HA, Lai K, et al. . Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell. (2017) 169:1119–1129. 10.1016/j.cell.2017.05.002
    1. Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, et al. . Foxp3+CD4+T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. (2014) 115:55–67. 10.1161/CIRCRESAHA.115.303895
    1. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. (1970) 18:723–37.
    1. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural selftolerance: deficit of a T-cell subset as a possible cause of autoimmune disease. J Exp Med. (1985) 161:72–87. 10.1084/jem.161.1.72
    1. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of non-mature CD4+8+ thymocytes. Nature. (1988) 333:742–6. 10.1038/333742a0
    1. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. (1994) 6:458–66. 10.1016/0952-7915(94)90128-7
    1. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science. (1994) 265:1237–40. 10.1126/science.7520605
    1. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol. (2002) 169:4850–60. 10.4049/jimmunol.169.9.4850
    1. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory Tcells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the non-redundant function of IL-2. Immunity. (2002) 17:167–78. 10.1016/S1074-7613(02)00367-9
    1. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. . Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. (2001) 27:68–73. 10.1038/83784
    1. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. . The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. (2001) 27:20–1. 10.1038/83713
    1. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. (2003) 299:1057–61. 10.1126/science.1079490
    1. Liu W, Putnam AL, Xu-yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med. (2006) 203:1701–11. 10.1084/jem.20060772
    1. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, et al. , Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity. (2004) 21:289–302. 10.1016/j.immuni.2004.07.016
    1. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol. (2007) 178:2018–27. 10.4049/jimmunol.178.4.2018
    1. Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity. (2006) 25:249–59. 10.1016/j.immuni.2006.05.016
    1. Wyss L, Stadinski BD, King CG, Schallenberg S, McCarthy NI, Lee JY, et al. . Affinity for self-antigen selects Treg cells with distinct functional properties. Nat Immunol. (2016) 17:1093–101. 10.1038/ni.3522
    1. Bolotin DA, Poslavsky S, Davydov AN, Frenkel FE, Fanchi L, Zolotareva OI, et al. . Antigen receptor repertoire profiling from RNA-seq data. Nat Biotechnol. (2017) 35:908–11. 10.1038/nbt.3979
    1. Izraelson M, Nakonechnaya TO, Moltedo B, Egorov ES, Kasatskaya SA, Putintseva EV, et al. . Comparative analysis of murine T-cell receptor repertoires. Immunology. (2018) 153:133–44. 10.1111/imm.12857
    1. Moran AE, Holzapfel KL, Xing Y, Cunningham NR, Maltzman JS, Punt J, et al. . T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. (2011) 208:1279–89. 10.1084/jem.20110308
    1. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, et al. . Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. (2001) 2:301–6. 10.1038/86302
    1. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, et al. , Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. (2012) 209:1713–22. 10.1084/jem.20120822
    1. Elkord E. Helios should not be cited as a marker of human thymus-derived Tregs. Commentary: Helios(+) and Helios(–) cells coexist within the natural FOXP3(+) T regulatory cell subset in humans. Front Immunol. (2016) 7:276 10.3389/fimmu.2016.00276
    1. Szurek E, Cebula A, Wojciech L, Pietrzak M, Rempala G, Kisielow P, et al. Differences in expression level of Helios and Neuropilin-1 do not distinguish thymus-derived from extrathymically-induced CD4+Foxp3+ regulatory T cells. PLoS ONE. (2015) 10:e0141161 10.1371/journal.pone.0141161
    1. Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. . Pathogenic conversion of Foxp3+ T-cells into TH17 cells in autoimmune arthritis. Nat Med. (2014) 20:62–70. 10.1038/nm.3432
    1. Chen D, Chen Y, Chen H, Hsieh C, Lin C, Lan J. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy. Arthritis Res Ther. (2011) 13:R126. 10.1186/ar3431
    1. Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T, et al. . Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. (2018) 8:7059. 10.1038/s41598-018-25384-x
    1. Yang BH, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M, et al. . Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. (2016) 9:444–57. 10.1038/mi.2015.74
    1. Feng Y, Arvey A, Chinen T, van der Veeken J, Gasteiger G, Rudensky AY. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell. (2014) 158:749–63. 10.1016/j.cell.2014.07.031
    1. Kitagawa Y, Ohkura N, Sakaguchi S. Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes. Front Immunol. (2013) 4:106. 10.3389/fimmu.2013.00106
    1. Sekiya T, Nakatsukasa H, Lu Q, Yoshimura A. Roles of transcription factors and epigenetic modifications in differentiation and maintenance of regulatory T cells. Microbes Infect. (2016) 18:378–86. 10.1016/j.micinf.2016.02.004
    1. Someya K, Nakatsukasa H, Ito M, Kondo T, Tateda KI, Akanuma T, et al. . Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation. Int Immunol. (2017) 29:365–75. 10.1093/intimm/dxx049
    1. Gratz IK, Truong H-A, Yang S-HY, Maurano MM, Lee K, Abbas AK, et al. Memory regulatory T cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. J Immunol. (2013) 190:4483–7. 10.4049/jimmunol.1300212
    1. Golubovskaya V, Wu L. Different subsets of T cells, memory, effector functions, and CAR-T. Cancers. (2016) 8:36. 10.3390/cancers8030036
    1. Matteucci E, Bartola LD, Giampietro O. Regulatory T cells with effector memory phenotype and glycaemic control in adult type 1 diabetes mellitus. J Diabetes Metab. (2013) S12:003 10.4172/2155-6156.S12-003
    1. Miragaia RJ, Gomes T, Chomka A, Jardine L, Riedel A, Hegazy AN, et al. . Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity. (2019) 50:493–504.e7. 10.1016/j.immuni.2019.01.001
    1. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med. (2002) 196:1079–90. 10.1084/jem.20020991
    1. Siegmund K, Feuerer M, Siewert C, Ghani S, Haubold U, Dankof A, et al. . Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood. (2005) 106:3097–104. 10.1182/blood-2005-05-1864
    1. Dudda JC, Perdue N, Bachtanian E, Campbell DJ. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med. (2008) 205:1559–65. 10.1084/jem.20072594
    1. Zhang N, Schröppel B, Lal G, Jakubzick C, Mao X, Chen D, et al. . Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. (2009) 30:458–469. 10.1016/j.immuni.2008.12.022
    1. Pohar J, Simon Q, Fillatreau S. Antigen-specificity in the thymic development and peripheral activity of CD4+FOXP3+ T regulatory cells. Front Immunol. (2018) 9:1701. 10.3389/fimmu.2018.01701
    1. Zemmour D, Zilionis R, Kiner E, Klein AM, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. (2018) 19:291–301. 10.1038/s41590-018-0051-0
    1. Sprouse ML, Shevchenko I, Scavuzzo MA, Joseph F, Lee T, Blum S, et al. . Cutting edge: low-affinity TCRs support regulatory T cell function in autoimmunity. J Immunol. (2017) 200:909–14. 10.4049/jimmunol.1700156
    1. Wei X, Zhang J, Gu Q, Huang M, Zhang W, Guo J, et al. Reciprocal expression of IL-35 and IL-10 defines two distinct effector Treg subsets that are required for maintenance of immune tolerance. Cell Rep. (2017) 27:1853–69. 10.1016/j.celrep.2017.10.090
    1. Okeke EB, Uzonna JE. The pivotal role of regulatory T cells in the regulation of innate immune cells. Front Immunol. (2019) 10:680. 10.3389/fimmu.2019.00680
    1. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, et al. . The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. (2009) 10:48–57. 10.1038/ni.1674
    1. Kučan BP, Lenac RT, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S. Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cell Mol Immunol. (2019) 16:40–52. 10.1038/s41423-018-0168-y
    1. Levine AG, Mendoza A, Hemmers S, Moltedo B, Niec RE, Schizas M, et al. . Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. (2017) 546:421–5. 10.1038/nature22360
    1. Joller N, Lozano E, Burkett PR, Patel B, Xiao S, Zhu C, et al. . Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. (2014) 40:569–81. 10.1016/j.immuni.2014.02.012
    1. Zheng Y, Chaudhry A, Kas A, de Roos P, Kim JM, Chu TT, et al. . Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. (2009) 458:351–6. 10.1038/nature07674
    1. Delacher M, Schmidl C, Herzig Y, Breloer M, Hartmann W, Brunk F, et al. . Rbpj expression in regulatory T cells is critical for restraining TH2 responses. Nat Commun. (2019) 10:1621. 10.1038/s41467-019-09276-w
    1. Koizumi SI, Sasaki D, Hsieh TH, Taira N, Arakaki N, Yamasaki S, et al. . JunB regulates homeostasis and suppressive functions of effector regulatory T cells. Nat Commun. (2018) 9:5344. 10.1038/s41467-018-07735-4
    1. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al. . CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science. (2009) 326:986–91. 10.1126/science.1172702
    1. Ghoreschi K, Laurence A, Yang XP, Hirahara K, O'Shea JJ. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. (2011) 32:395–401. 10.1016/j.it.2011.06.007
    1. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA. (2008) 105:10113–8. 10.1073/pnas.0711106105
    1. Akkaya B, Akkaya M, Kamenyeva O, Kabat J, Dorward DW, Holstein AH, et al. Unique interaction dynamics and peptide-MHC class II (pMHC II) transendocytosis lead to antigen-specific T regulatory cell (Treg)-mediated suppression. J Immunol. (2017) 198(Suppl. 1):80.8.
    1. Akkaya B, Akkaya M, Oya Y, Souz JA, Holstein AH, Kamenyeva O, et al. Tregs orchestrate antigen specific suppression via stripping cognate peptide-MHCII from the DC surface. J Immunol. (2018) 200(Suppl. 1):47.20.
    1. Akkaya B, Oya Y, Akkaya M, Al Souz J, Holstein AH, Kamenyeva O, et al. . Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells. Nat Immunol. (2019) 20:218–31. 10.1038/s41590-018-0280-2
    1. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. . Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. (2003) 4:1206–12. 10.1038/ni1003
    1. Ernst PB, Garrison JC, Thompson LF. Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J Immunol. (2010) 185:1993–8. 10.4049/jimmunol.1000108
    1. Zhu Z, Zhang Y, Ye J, Wang X, Fu X, Yin Y, et al. . IL-35 promoted STAT3 phosphorylation and IL-10 production in B cells, but its production was reduced in patients with coronary artery diseases. Hum Immunol. (2018) 79:869–75. 10.1016/j.humimm.2018.10.009
    1. Tsuchida Y, Sumitomo S, Ishigaki K, Suzuki A, Kochi Y, Tsuchiya H, et al. . TGF-β3 inhibits antibody production by human B cells. PLoS ONE. (2017) 12:e0169646. 10.1371/journal.pone.0169646
    1. Dooley A, Quintana M, Cheung M, Sun L, Gupta N. The B cell IL-10 receptor suppresses antibody production. J Immunol. (2018) 200(Suppl. 1):164.9.
    1. Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of Treg-mediated T cell suppression. Front Immunol. (2012) 3:51. 10.3389/fimmu.2012.00051
    1. Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, Brinke A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction–a comparative study of human clinical-applicable DC. Clin Immunol. (2012) 142:332–42. 10.1016/j.clim.2011.11.011
    1. Strobl H, Knapp W. TGF-beta1 regulation of dendritic cells. Microbes Infect. (1999) 1:1283–90. 10.1016/S1286-4579(99)00256-7
    1. Wallet MA, Sen P, Tisch R. Immunoregulation of dendritic cells. Clin Med Res. (2005) 3:166–75. 10.3121/cmr.3.3.166
    1. Speck S, Lim J, Shelake S, Matka M, Stoddard J, Farr A, et al. . TGF-β signaling initiated in dendritic cells instructs suppressive effects on Th17 differentiation at the site of neuroinflammation. PLoS ONE. (2014) 9:e102390. 10.1371/journal.pone.0102390
    1. Thepmalee C, Panya A, Junking M, Chieochansin T, Yenchitsomanus PT. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells. Hum Vaccin Immunother. (2018) 14:1423–31. 10.1080/21645515.2018.1431598
    1. Safinia N, Scotta C, Vaikunthanathan T, Lechler RI, Lombardi G. Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation. Front Immunol. 6:438. 10.3389/fimmu.2015.00438
    1. Schwarz A, Schumacher M, Pfaff D, Schumacher K, Jarius S, Balint B, et al. . Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis. J Immunol. (2013) 190:4965–70. 10.4049/jimmunol.1203224
    1. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. (2004) 21:589–601. 10.1016/j.immuni.2004.09.002
    1. Ren X, Ye F, Jiang Z, Chu Y, Xiong S, Wang Y. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells. Cell Death Differ. (2007) 14:2076–84. 10.1038/sj.cdd.4402220
    1. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, et al. . TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol. (2000) 2:241–3. 10.1038/35008667
    1. Gianchecchi E, Fierabracci A. Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in Treg development and their involvement in autoimmunity onset and cancer progression. Front Immunol. (2018) 9:2374. 10.3389/fimmu.2018.02374
    1. Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y, et al. An essential role for IL-2 receptor in regulatory T cell function. Nat Immunol. (2016) 17:1322–33. 10.1038/ni.3540
    1. Peiser M, Becht A, Wanner R. Antibody blocking of MHC II on human activated regulatory T cells abrogates their suppressive potential. Allergy. (2007) 62:773–80. 10.1111/j.1398-9995.2007.01339.x
    1. Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol. (2006) 176:4622–31. 10.4049/jimmunol.176.8.4622
    1. Li J, Tan J, Martino MM, Lui KO. Regulatory T-cells: potential regulator of tissue repair and regeneration. Front Immunol. (2018) 9:585. 10.3389/fimmu.2018.00585
    1. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. . A special population of regulatory T cells potentiates muscle repair. Cell. (2013) 155:1282–95. 10.1016/j.cell.2013.10.054
    1. Rieckmann M, Delgobo M, Gaal C, Büchner L, Steinau P, Reshef D, et al. . Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest. (2019) 130:4922–36. 10.1172/JCI123859
    1. Vahl JC, Drees C, Heger K, Heink S, Fischer JC, Nedjic J, et al. . Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity. (2014) 41:722–36. 10.1016/j.immuni.2014.10.012
    1. Schmidt AM, Lu W, Sindhava VJ, Huang Y, Burkhardt JK, Yang E, et al. . Regulatory T cells require TCR signaling for their suppressive function. J Immunol. (2015) 194:4362–70. 10.4049/jimmunol.1402384
    1. Golovina TN, Mikheeva T, Suhoski MM, Aqui NA, Tai VC, Shan X, et al. . CD28 costimulation is essential for human T regulatory expansion and function. J Immunol. (2008) 181:2855–68. 10.4049/jimmunol.181.4.2855
    1. He X, Smeets RL, van Rijssen E, Boots AM, Joosten I, Koenen HJ. Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells. Sci Rep. (2017) 7:43003. 10.1038/srep43003
    1. Jeon PH, Oh KI. IL2 is required for functional maturation of regulatory T cells. Anim Cells Syst. (2017) 21:1–9. 10.1080/19768354.2016.1272489
    1. Fan MY, Low JS, Tanimine N, Finn KK, Priyadharshini B, Germana SK, et al. . Differential roles of IL-2 signaling in developing versus mature Tregs. Cell Rep. (2018) 25:1204–13.e4. 10.1016/j.celrep.2018.10.002
    1. Liu Z, Gerner MY, Van Panhuys N, Levine AG, Rudensky AY, Germain RN. Immune homeostasis enforced by co-localized effector and regulatory T cells. Nature. (2015) 528:225–30. 10.1038/nature16169
    1. Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, Garbi N, et al. . Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol. (2010) 184:1810–20. 10.4049/jimmunol.0902420
    1. Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, et al. . Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med. (2009) 206:1853–62. 10.1084/jem.20090746
    1. Bar-On L, Birnberg T, Kim KW, Jung S. Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur J Immunol. (2011) 41:291–8. 10.1002/eji.201041169
    1. Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, et al. . Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol. (2003) 3348–52. 10.4049/jimmunol.171.7.3348
    1. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol. (2004) 172:2778–84. 10.4049/jimmunol.172.5.2778
    1. Almeida AR, Zaragoza B, Freitas AA. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol. (2006) 177:192–200. 10.4049/jimmunol.177.1.192
    1. Chen S, Fang L, Guo W, Zhou Y, Yu G, Li W, et al. . Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells. Nat Commun. (2018) 9:5298. 10.1038/s41467-018-07545-8
    1. Silva SL, Albuquerque AS, Serra-Caetano A, Foxall RB, Pires AR, Matoso P, et al. . Human naive regulatory T-cells feature high steady-state turnover and are maintained by IL-7. Oncotarget. (2016) 7:12163–75. 10.18632/oncotarget.7512
    1. Schadenberg AW, van den Broek T, Siemelink MA, Algra SO, de Jong PR, Jansen NJ, et al. . Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy. J Allergy Clin Immunol. (2014) 133:277–80.e1–6. 10.1016/j.jaci.2013.08.030
    1. Smigiel KS, Richards E, Srivastava S, Thomas KR, Dudda JC, Klonowski KD, et al. . CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. J Exp Med. (2014) 211:121–36. 10.1084/jem.20131142
    1. Long M, Adler AJ. Cutting edge: paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J Immunol. (2006) 177:4257–61. 10.4049/jimmunol.177.7.4257
    1. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK. Response to self-antigen imprints regulatory memory in tissues. Nature. (2011) 480:538–42. 10.1038/nature10664
    1. Levine AG, Arvey A, Jin W, Rudensky AY. Continuous requirement for the TCR in regulatory T cell function. Nat Immunol. (2014) 15:1070–8. 10.1038/ni.3004
    1. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol. (2009) 10:595–602. 10.1038/ni.1731
    1. Huber M, Lohoff M. IRF4 at the crossroads of effector T-cell fate decision. Eur J Immunol. (2014) 44:1886–95. 10.1002/eji.201344279
    1. Chen Q, Mo L, Cai X, Wei L, Xie Z, Li H, et al. . ICOS signal facilitates Foxp3 transcription to favor suppressive function of regulatory T cells. Int J Med Sci. (2018) 15:666–73. 10.7150/ijms.23940
    1. Landuyt AE, Klocke BJ, Colvin TB, Schoeb TR, Maynard CL. Cutting edge: ICOS-deficient regulatory T cells display normal induction of Il10 but readily downregulate expression of Foxp3. J Immunol. (2019) 202:1039–44. 10.4049/jimmunol.1801266
    1. Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam KP, Coyle AJ, et al. . ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol. (2008) 180:774–82. 10.4049/jimmunol.180.2.774
    1. Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med. (2004) 199:1479–89. 10.1084/jem.20040179
    1. Niven J, Madelon N, Page N, Caruso A, Harlé G, Lemeille S, et al. . Macroautophagy in dendritic cells controls the homeostasis and stability of regulatory T cells. Cell Rep. (2019) 28:21–29.e6. 10.1016/j.celrep.2019.05.110
    1. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM, et al. . Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. (2011) 34:566–78. 10.1016/j.immuni.2011.03.018
    1. Zhang Q, Lu W, Liang CL, Chen Y, Liu H, Qiu F, et al. . Chimeric antigen receptor (CAR) Treg: a promising approach to inducing immunological tolerance. Front Immunol. (2018) 9:2359. 10.3389/fimmu.2018.02359
    1. Ahmadzadeh M, Pasetto A, Jia L, Deniger DC, Stevanovic S, Robbins PF, et al. . Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Sci Immunol. (2019) 4:eaao4310. 10.1126/sciimmunol.aao4310
    1. Bacher P, Heinrich F, Stervbo U, Nienen M, Vahldieck M, Iwert C, et al. . Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell. (2016) 167:1067–78.e16. 10.1016/j.cell.2016.09.050
    1. Egorov ES, Kasatskaya SA, Zubov VN, Izraelson M, Nakonechnaya TO, Staroverov DB, et al. . The changing landscape of naive T cell receptor repertoire with human aging. Front Immunol. (2018) 9:1618. 10.3389/fimmu.2018.01618
    1. Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, et al. . Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci USA. (2014) 111:13139–44. 10.1073/pnas.1409155111

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe